International cooperation USA in biological and biotechnological R&D: directional dynamics and spatial structure

The long dominance of the United States of America in many areas of international trade has determined its central place in the global market for biological and biotechnological research and development, the implementation of which in various regions and countries of the world is controlled not only by the federal government, but also by transnational corporations and non- profit international organizations affiliated with the United States. Considering the complexity of studying trade and intermediary chains in a globalized world, the author made an attempt to study the industry dynamics and spatial structure of US international cooperation in the field of biological and biotechnological R&D since the early 1950s. and until 2020 based on the results of an economic and statistical analysis of the absolute and relative indicators of their financing by various American customers. The data obtained made it possible to identify a number of structural and dynamic trends in the cooperation under study in the context of specific areas. Based on the well-known theoretical and factual data, confirmed by the empirical results of this study, the fundamental importance of the US expansion in the field of biological and biotechnological R&D, which is constantly growing in time and expanding in the world space, is seen as one of the tools for preserving by the largest American business and power not only economic, but also political influence, through the stabilization of the "American-centric" world- system, the stability of which is under threat.